Show simple item record

dc.contributor.authorTECER, A
dc.contributor.authorDEMIRALP, Tamer
dc.contributor.authorDEVRIM, M
dc.contributor.authorPOLICH, J
dc.contributor.authorIsoglu-Alkac, U
dc.contributor.authorUCOK, A
dc.date.accessioned2021-03-05T12:21:36Z
dc.date.available2021-03-05T12:21:36Z
dc.identifier.citationDEMIRALP T., UCOK A., DEVRIM M., Isoglu-Alkac U., TECER A., POLICH J., "N2 and P3 components of event-related potential in first-episode schizophrenic patients: scalp topography, medication, and latency effects", PSYCHIATRY RESEARCH, cilt.111, ss.167-179, 2002
dc.identifier.issn0165-1781
dc.identifier.othervv_1032021
dc.identifier.otherav_accd9bc2-a472-43b9-8ae8-3b83108b6fd6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/115306
dc.identifier.urihttps://doi.org/10.1016/s0165-1781(02)00133-6
dc.description.abstractAuditory N2 and P3 components of event-related potentials were assessed in first-episode schizophrenic and normal control subjects (n = 12/group). P3 amplitude was decreased in the patients most prominently over the frontal areas in contrast to a widespread P3 amplitude decrease reported in chronic schizophrenia. Moreover, frontal attenuation of P3 amplitude was greater in the non-medicated compared with medicated patients, a finding that suggests frontal areas are primarily affected at the onset of the first schizophrenic episode. Prolongation of N2 and P3 latencies was also observed in the patients, which indicates that stimulus classification and memory updating processes were slowed even in early stages of schizophrenia. These findings indicate that first-episode schizophrenic patients produce N2 and P3 abnormalities that are distinct from those in chronic patients, and that psychotropic medication can attenuate event-related potential effects in specific ways. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
dc.language.isoeng
dc.subjectPsikiyatri
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.titleN2 and P3 components of event-related potential in first-episode schizophrenic patients: scalp topography, medication, and latency effects
dc.typeMakale
dc.relation.journalPSYCHIATRY RESEARCH
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume111
dc.identifier.startpage167
dc.identifier.endpage179
dc.contributor.firstauthorID32133


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record